Alteration of DNA Methylation in Gastric Cancer with Chemotherapy

키워드

참고문헌 (39)

1. Baylin SB., "DNA methylation and gene silencing in cancer", Nat. Rev. Clin. Oncol, 2, pp.S4~ (2005)
2. Das PM, "DNA methylation and cancer", J. Clin. Oncol, 22, pp.4632~4642 (2004)
3. Fu D-G., "Epigenetic alterations in gastric cancer (Review)", Mol. Med. Rep, 12, pp.3223~3230 (2015)
4. Kang C, "Epigenetics: an emerging player in gastric cancer", World J. Gastroenterol, 20, pp.6433~6447 (2014)
5. Etoh T, "Increased DNA methyltransferase 1(DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers", Am. J. Pathol, 164, pp.689~699 (2004)
6. Li L, "Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers", Sci. Rep, 6, pp.26591~ (2016)
7. Holohan C, "Cancer drug resistance: an evolving paradigm", Nat. Rev. Cancer, 13, pp.714~726 (2013)
8. Housman G, "Drug resistance in cancer: an overview", Cancers, 6, pp.1769~1792 (2014)
9. Chen C-C, "Changes in DNA methylation are associated with the development of drug resistance in cervical cancer cells", Cancer Cell Int, 15, pp.98~ (2015)
10. Carcas LP., "Gastric cancer review", J. Carcinog, 13, pp.14~ (2014)
11. Guo X, "Promoter methylated microRNAs:potential therapeutic targets in gastric cancer (Review)", Mol. Med. Rep, 11, pp.759~765 (2015)
12. Ivanova T, "Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer", Gut, 62, pp.22~33 (2013)
13. Kang KA, "Epigenetic modification of Nrf2 in 5-fluorouracilresistant colon cancer cells: involvement of TET-dependent DNA demethylation", Cell Death Dis, 5, pp.e1183~ (2014)
14. Mitsuno M, "Aberrant methylation of p16 predicts candidates for 5-fluorouracil-based adjuvant therapy in gastric cancer patients", J. Gastroenterol, 42, pp.866~873 (2007)
15. Florea A-M, "Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects", Cancers, 3, pp.1351~1371 (2011)
16. Stewart DJ., "Mechanisms of resistance to cisplatin and carboplatin", Crit. Rev. Oncol. Hematol, 63, pp.12~31 (2007)
17. Napieralski R, "Methylation of tumor-related genes in neoadjuvant-treated gastric cancer: relation to therapy response and clinicopathologic and molecular features", Clin. Cancer Res, 13, pp.5095~5102 (2007)
18. Kato K, "Methylated TMS1 and DAPK genes predict prognosis and response to chemotherapy in gastric cancer", Int. J. Cancer, 122, pp.603~608 (2008)
19. Kwon OH, "Aberrant upregulation of ASCL2 by promoter demethylation promotes the growth and resistance to 5-fluorouracil of gastric cancer cells", Cancer Sci, 104, pp.391~397 (2013)
20. Hu X, "Protocadherin 17 acts as a tumour suppressor inducing tumour cell apoptosis and autophagy, and is frequently methylated in gastric and colorectal cancers", J. Pathol, 229, pp.62~73 (2013)
21. Maeda O, "Alteration of gene expression and DNA methylation in drug-resistant gastric cancer", Oncol. Rep, 31, pp.1883~1890 (2014)
22. Xia LL, "DCTPP1 attenuates the sensitivity of human gastric cancer cells to 5-fluorouracil by up-regulating MDR1 expression epigenetically", Oncotarget, 7, pp.68623~68637 (2016)
23. Zhang Y, "dCTP Pyrophosphohydrase exhibits nucleic accumulation in multiple carcinomas", Eur. J. Histochem, 57, pp.e29~ (2013)
24. Sun J, "Transcription factor AP2ε", Technol. Cancer Res. Treat, 15, pp.285~295 (2016)
25. Zhang Y, "GSTP1 determines cis-platinum cytotoxicity in gastric adenocarcinoma MGC803 cells: regulation by promoter methylation and extracellular regulated kinase signaling", Anti cancer Drugs, 20, pp.208~214 (2009)
26. Shen J, "SULF2 methylation is associated with in vitro cisplatin sensitivity and clinical efficacy for gastric cancer patients treated with a modified FOLFOX regimen", PLoS One, 8, pp.e75564~ (2013)
27. Zhou W, "siRNA silencing EZH2 reverses cisplatin-resistance of human non-small cell lung and gastric cancer cells", Asian Pac. J. Cancer Prev, 16, pp.2425~2430 (2015)
28. Subhash VV, "GTSE1 expression represses apoptotic signaling and confers cisplatin resistance in gastric cancer cells", BMC Cancer, 15, pp.550~ (2015)
29. Yeh CM, "Epigenetic silencing of the NR4A3 tumor suppressor, by aberrant JAK", STAT signaling, predicts prognosis in gastric cancer, 2016, pp.6, 31690~
30. 전미성, "Aberrant Epigenetic Modifications of LPHN2 Function as a Potential Cisplatin-Specific Biomarker for Human Gastrointestinal Cancer", Cancer Research and Treatment, 48(2), pp.676~686 (2016), 대한암학회
31. Su C, "Long noncoding RNA HOTAIR promotes cisplatin resistance in gastric cancer through promoting WIF-1 promoter methylation", Int. J. Clin. Exp. Med, 10, pp.2717~2726 (2017)
32. Sugita H, "Methylation of BNIP3 and DAPK indicates lower response to chemotherapy and poor prognosis in gastric cancer", Oncol. Rep, 25, pp.513~ (2011)
33. Ooki A, "DNA damage-inducible gene, reprimo functions as a tumor suppressor and is suppressed by promoter methylation in gastric cancer", Mol. Cancer Res, 11, pp.1362~1374 (2013)
34. Wu Q, "Methylation of miR-129-5p CpG island modulates multidrug resistance in gastric cancer by targeting ABC transporters", Oncotarget, 5, pp.11552~11563 (2014)
35. Yu Y, "DACT2is frequently methylated in human gastric cancer and methylation of DACT2 activated Wnt signaling", Am. J. Cancer Res, 4, pp.710~ (2014)
36. Gou WF, "The roles of BTG3 expression in gastric cancer: a potential marker for carcinogenesis and a target molecule for gene therapy", Oncotarget, 6, pp.19841~19867 (2015)
37. Mi H, "PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees", Nucleic Acids Res, 41, pp.D377~D386 (2013)
38. Chen EY, "Enrichr: interactive and collaborative HTML5gene list enrichment analysis tool", BMC Bioinformatics, 14, pp.128~ (2013)
39. Gottesman MM., "Mechanisms of cancer drug resistance", Annu. Rev. Med, 53, pp.615~627 (2002)

관련 논문AI추천